These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Clopidogrel in acute coronary syndrome: implications of recent study findings. Duerschmied D; Bode C; Moser M Expert Rev Cardiovasc Ther; 2010 Sep; 8(9):1215-29. PubMed ID: 20828343 [TBL] [Abstract][Full Text] [Related]
26. GP IIb-IIIa inhibitors administered upstream: evidence for improved outcomes with conventional and newer antithrombotic agents? Tricoci P; Newby LK Cardiol Rev; 2008; 16(2):89-94. PubMed ID: 18281911 [TBL] [Abstract][Full Text] [Related]
27. Bleeding and the use of antiplatelet agents in the management of acute coronary syndromes and atrial fibrillation. Vavalle JP; Rao SV Adv Cardiol; 2012; 47():125-40. PubMed ID: 22906908 [TBL] [Abstract][Full Text] [Related]
29. Clinical impact of enhanced inhibition of P2Y12-mediated platelet aggregation in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. Capranzano P; Mehran R; Tamburino C; Stone GW; Dangas G Hosp Pract (1995); 2010 Nov; 38(4):38-43. PubMed ID: 21068525 [TBL] [Abstract][Full Text] [Related]
30. Challenges in managing venous thromboembolism and acute coronary syndrome: case studies of the use of antithrombotic and antiplatelet therapies. Introduction. Haines ST Am J Health Syst Pharm; 2008 Aug; 65(15 Suppl 7):S3-4. PubMed ID: 18653823 [No Abstract] [Full Text] [Related]
34. Antithrombotic and antiplatelet therapies in relation to risk stratification in patients with non-ST elevation acute coronary syndrome: insights from the Sino-Global Registry of Acute Coronary Events. Zhang LJ; Chen YD; Song XT; Zhao FH; Lü SZ Chin Med J (Engl); 2009 Mar; 122(5):502-8. PubMed ID: 19323898 [TBL] [Abstract][Full Text] [Related]
35. Antithrombotic therapy in medically managed patients with non-ST-segment elevation acute coronary syndromes. Gurbel PA; Tantry US Heart; 2016 Jun; 102(11):882-92. PubMed ID: 26944654 [No Abstract] [Full Text] [Related]
36. Glycoprotein IIb/IIIa receptor inhibitors in 2008: do they still have a role? Mukherjee D; Roffi M J Interv Cardiol; 2008 Apr; 21(2):118-21. PubMed ID: 18384343 [No Abstract] [Full Text] [Related]
37. Novel platelet ADP P2Y12 inhibitors in the treatment of acute coronary syndrome. Tan GM; Lam YY; Yan BP Cardiovasc Ther; 2012 Aug; 30(4):e167-73. PubMed ID: 21883998 [TBL] [Abstract][Full Text] [Related]